Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya

Table 3 Molecular subtypes

Variable	Characteristics	N (%)
Luminal A	ER+ and/or PR+, HER2−, low Ki-67	7 (14)
Luminal B	ER+ and/or PR+, HER2+ (or HER2− with high Ki-67)	20 (41)
Her2	ER− and/or PR-, Her2 + Any Ki-67	4 (8)
Basal/triple negative	ER−, PR−, HER2− and any Ki-67	18 (37)

ER+/- estrogen receptor positive or negative, PR+/- progesterone receptor positive or negative, HER2 +/- human epidermal growth factor positive or negative

ISSN: 1349-4147